Work

Editorial: higher levels of certain serum bile acids in non‐alcoholic fatty liver disease–new insights from Guatemala.Authors’ reply

Year: 2022

Type: editorial

Abstract: LINKED CONTENT This article is linked to Rivera–Andrade et al papers. To view these articles, visit https://doi.org/10.1111/apt.16948 and https://doi.org/10.1111/apt.16962

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.17061

Authors: Alvaro Rivera‐Andrade, Jessica L. Petrick, Christian S. Alvarez, Barry I. Graubard, Andrea A. Florio, Maria F. Kroker‐Lobos, Dominick Parisi, Neal D. Freedman, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramirez‐Zea, Katherine A. McGlynn

Institutions: Institute of Nutrition of Central America and Panama, Boston University, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Harvard University, Information Management Services, Johns Hopkins University

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Research Committee, Aristotle University of Thessaloniki, National Cancer Institute

Award: Regional Oncology Research Center

OpenAlex ID: W4283386374

Cites: 2

Cited by:

Related to: 10